19.07
2.05%
-0.40
プレマーケット:
19.14
0.07
+0.37%
Schrodinger Inc (SDGR) 最新ニュース
Goldman Sachs maintains Schrodinger stock at Neutral By Investing.com - Investing.com Canada
Goldman Sachs maintains Schrodinger stock at Neutral - Investing.com India
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities - Yahoo Finance
Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
(SDGR) Technical Pivots with Risk Controls - Stock Traders Daily
Top 5 AI & Digital Biotech Companies (January 2025) - Securities.io
Schrödinger (NASDAQ:SDGR) Shares Up 3.4%What's Next? - MarketBeat
Schrödinger (NASDAQ:SDGR) Shares Down 6.7%Time to Sell? - MarketBeat
Barclays PLC Increases Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Jane Street Group LLC Has $1.80 Million Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
State Street Corp Has $39.99 Million Stake in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)December 17, 2024 - BioSpace
Schrödinger Awards Inducement RSU Grants to New Employees Under 2021 Equity Plan - StockTitan
Schrödinger, Inc. (NASDAQ:SDGR) Receives $32.90 Consensus PT from Brokerages - MarketBeat
(SDGR) Investment Analysis and Advice - Stock Traders Daily
Biosimulation Industry Forecast, 2029: Analysis of Case Studies, Market Dynamics, Regional Growth Trends, Regulatory Landscape, Value Chain, and Competitive Intelligence - GlobeNewswire Inc.
How To Trade (SDGR) - Stock Traders Daily
Schrodinger Inc (SDGR) Trading Down 4.58% on Dec 5 - GuruFocus.com
Parkman Healthcare Partners LLC Trims Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Material Informatics Market Top Companies Study -Citrine - openPR
Rubric Capital Management LP Has $68.37 Million Holdings in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger, Inc. (NASDAQ:SDGR) Stock Position Increased by Algert Global LLC - MarketBeat
Schrodinger Inc (SDGR) Stock Price Down 3.17% on Nov 26 - GuruFocus.com
Massachusetts Financial Services Co. MA Purchases 717,059 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates - MSN
Detailed Analysis of Molecular Modeling for Drug Development - openPR
Quest Partners LLC Purchases 39,218 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger, Inc. (NASDAQ:SDGR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Schrödinger: Positive Signs Despite The Share Price Decline (SDGR) - Seeking Alpha
Gates Foundation awards second predictive toxicology grant - Philanthropy News Digest
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference - Business Wire
Schrödinger’s stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion - MSN
Schrödinger, Novartis Ink Up-to-$2.3B Collaboration, Software Agreement - Genetic Engineering & Biotechnology News
SDGRSchrodinger, Inc. Latest Stock News & Market Updates - StockTitan
Schrödinger, Inc. Receives an Additional $9.5 Million from the Bill & Melinda Gates Foundation - Marketscreener.com
Biosimulation Market Dynamics and Future Opportunities | 2024 - openPR
Schrödinger Awards RSU Grants to New Employees Under Inducement Plan - StockTitan
Schrödinger Broadens and Accelerates Predictive Toxicology Initiative - BioSpace
Schrödinger Secures $9.5M Gates Foundation Grant to Expand Drug Discovery Platform - StockTitan
Sumitomo Mitsui Trust Group Inc. Increases Stake in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Leerink Partnrs Decreases Earnings Estimates for Schrödinger - MarketBeat
(SDGR) Technical Data - Stock Traders Daily
Schrodinger Inc (SDGR) Quarterly 10-Q Report - Quartz
Schrodinger (SDGR): Stock Experiences 5% Decline Amid Market Flu - GuruFocus.com
Pier 88 Investment Partners LLC Buys 35,120 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Midtown-based drug company inks $150M deal with Novartis - Crain's New York Business
Rubric Capital Management LP Increases Stake in Schrodinger Inc - GuruFocus.com
Schrödinger, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2024 - Marketscreener.com
Schrodinger shares target increased, outperform rating on Novartis deal - Investing.com
Flare and Schrödinger join multibillion-dollar collaborations - BioWorld Online
Schrödinger announces collaboration with Novartis - The Pharma Letter
Schrödinger, Inc. (NASDAQ:SDGR) Q3 2024 Earnings Call Transcript - Insider Monkey
大文字化:
|
ボリューム (24 時間):